PSVIII-19 Acute metabolic responses to a combined viral-bacterial respiratory disease challenge in heifers administered transdermal flunixin meglumine.
نویسندگان
چکیده
منابع مشابه
Flunixin Meglumine as Adjunct Therapy for Bovine Respiratory Disease in Stocker Cattle
Bovine respiratory disease (BRD) is a complex syndrome caused by several viruses complicated by secondary bacterial infections. The economic consequences of this syndrome are considerable, in terms of loss from death, decreased growth performance, increased medication costs, and labor. There is a wide variety of therapeutic options, most of which involve the use of antibiotics. There is increas...
متن کاملSerum Acute-Phase Inflammation Proteins as a Means of Assessing Effectiveness of Flunixin Meglumine Therapy for Bovine Respiratory Disease
The economic consequences of bovine respiratory disease (BRD) in weaned calves and stocker cattle are considerable in terms of loss from death, decreased growth performance, increased medication costs, and labor. It is a complex disease involving both viruses and bacteria. The inflammation that accompanies BRD can result in permanent lung damage. The goals of therapeutic treatment for BRD are t...
متن کاملEffect of the administration of flunixin meglumine on pregnancy rates in Holstein heifers.
Fifty-two 15-month-old Holstein heifers were synchronised with single or double injections of prostaglandin F(2alpha), followed by an injection of gonadotrophin-releasing hormone (gnrh) 48 hours later, and inseminated 12 to 14 hours after the injection of gnrh (day 0). Half of them were then injected twice intramuscularly with 1.1 mg/kg flunixin meglumine 12 hours apart, on the evening of day 1...
متن کاملToxicity of Flunixin Meglumine in Broiler Chickens
This study was designed to evaluate the toxicity of flunixin meglumine, a nonsteroidal anti-inflammatory drug which might serve as an alternate of diclofenac that has been shown to cause toxicity in vultures. Twenty five broiler chickens of five weeks of age were randomly divided into five equal groups and treated with flunixin meglumine at the dosage rate of 0, 1.25, 2.5, 5 and 10 mg/kg body w...
متن کاملFrequency of resistance to systemically administered Meglumine Antimoniate (Glucantime) in patients with acute cutaneous Leishmaniasis: A cross-sectional study
Background and aim: Pentavalent antimony compounds are the first line treatment for cutaneous leishmaniasis. Clinical resistance to pentavalent antimony in the form of meglumine antimoniate (Glucantime) has been recognized as a problem in leishmaniasis. Herein, clinical response to Glucantime were studied in patients suffered from cutaneous leishmaniasis.Materials and Methods: In a cross-sectio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Animal Science
سال: 2018
ISSN: 0021-8812,1525-3163
DOI: 10.1093/jas/sky404.065